Evidence map›Paper›PMID 18438844›Full record

ArticleArthritis and rheumatism2008

Expression of microRNA-146 in rheumatoid arthritis synovial tissue.

Tomoyuki Nakasa, Shigeru Miyaki, Atsuko Okubo, Megumi Hashimoto, Keiichiro Nishida, Mitsuo Ochi, Hiroshi Asahara

Open access · greenAbstract read
In one paragraph

Article in Arthritis and rheumatism, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 280 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
280citing papers in PubMed, 6 pooled it
18.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

280 citing papers in PubMed, 6 syntheses or guidelines pooled it, 670 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Genetic variant inAnnals of medicine · 2021
    Pooled it
  4. Pooled it
  5. The role of microRNAs in oral lichenoid disorders. Systematic review.Medicina oral, patologia oral y cirugia bucal · 2017
    Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Plasma levels of microRNA in chronic kidney disease: patterns in acute and chronic exercise.American journal of physiology. Heart and circulatory physiology · 2015
    Trial
  11. Trial
  12. Review
  13. Review
  14. Article
  15. microRNAs as Biomarkers and Therapeutic Targets in Rheumatoid Arthritis.International journal of molecular sciences · 2025
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

220 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Tomoyuki NakasaNational Research Institute for Child Health and Development, Tokyo, Japan.
Shigeru Miyaki
Atsuko Okubo
Megumi Hashimoto
Keiichiro Nishida
Mitsuo Ochi
Hiroshi Asahara
National Center For Child Health and Development · JPHiroshima University · JPOkayama University · JPScripps Research Institute · US

Funding

Transcriptional Regulation of ChondrogenesisR01AR050631 · NIAMS · SCRIPPS RESEARCH INSTITUTE, THE · PI ASAHARA, HIROSHI · 2004 to 2021
$5.8M
RHEUMATIC DISEASES CORE CENTERP30AR047360 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SILVERMAN, GREGG JOSHUA · 2001 to 2006
$3.4M
The role of microRNAs in chondrogenesis and arthritisR56AR050631 · NIAMS · SCRIPPS RESEARCH INSTITUTE, THE · PI ASAHARA, HIROSHI · 2009 to 2009
$475k
NIAMS NIH HHS AR-47360NIAMS NIH HHS AR-50631NIAMS NIH HHS P30 AR047360NIAMS NIH HHS R01 AR050631NIAMS NIH HHS R56 AR050631
6 · The paper itself

Abstract

objectiveSeveral microRNA, which are approximately 22-nucleotide noncoding RNAs, exhibit tissue-specific or developmental stage-specific expression patterns and are associated with human diseases. The objective of this study was to identify the expression pattern of microRNA-146 (miR-146) in synovial tissue from patients with rheumatoid arthritis (RA).

methodsThe expression of miR-146 in synovial tissue from 5 patients with RA, 5 patients with osteoarthritis (OA), and 1 normal subject was analyzed by quantitative reverse transcription-polymerase chain reaction (RT-PCR) and by in situ hybridization and immunohistochemistry of tissue sections. Induction of miR-146 following stimulation with tumor necrosis factor alpha (TNFalpha) and interleukin-1beta (IL-1beta) of cultures of human rheumatoid arthritis synovial fibroblasts (RASFs) was examined by quantitative PCR and RT-PCR.

resultsMature miR-146a and primary miR-146a/b were highly expressed in RA synovial tissue, which also expressed TNFalpha, but the 2 microRNA were less highly expressed in OA and normal synovial tissue. In situ hybridization showed primary miR-146a expression in cells of the superficial and sublining layers in synovial tissue from RA patients. Cells positive for miR-146a were primarily CD68+ macrophages, but included several CD3+ T cell subsets and CD79a+ B cells. Expression of miR-146a/b was markedly up-regulated in RASFs after stimulation with TNFalpha and IL-1beta.

conclusionThis study shows that miR-146 is expressed in RA synovial tissue and that its expression is induced by stimulation with TNFalpha and IL-1beta. Further studies are required to elucidate the function of miR-146 in these tissues.

Indexed as

AdultAgedArthritis, RheumatoidFemaleHumansMaleMicroRNAsMiddle AgedSynovial MembraneMicroRNAs

Identifiers

PMID18438844
PMCPMC2749927
OpenAlexW1974976948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.